Definium Therapeutics, Inc.
DFTX
$42.63
-$1.27-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -353.79M | -237.54M | -183.79M | -168.10M | -114.52M |
| Total Depreciation and Amortization | -- | -- | -- | -527.00K | -527.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 527.00K | 527.00K |
| Total Other Non-Cash Items | 170.29M | 75.43M | 42.80M | 40.66M | 6.55M |
| Change in Net Operating Assets | 15.54M | 17.35M | 9.44M | 13.50M | 6.41M |
| Cash from Operations | -167.95M | -144.77M | -131.56M | -113.94M | -101.56M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -224.35M | 52.85M | -151.61M | -186.59M | -202.00M |
| Cash from Investing | -224.35M | 52.85M | -151.61M | -186.59M | -202.00M |
| Total Debt Issued | 0.00 | 42.00M | 42.00M | 42.00M | 42.00M |
| Total Debt Repaid | 0.00 | -22.00M | -22.00M | -22.00M | -22.00M |
| Issuance of Common Stock | 1.08B | 267.97M | 263.66M | 5.73M | 80.01M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -62.36M | -16.39M | -16.39M | -522.00K | -6.20M |
| Cash from Financing | 1.01B | 271.58M | 267.27M | 25.21M | 93.81M |
| Foreign Exchange rate Adjustments | -18.00K | 8.00K | -7.00K | -7.00K | 3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 621.88M | 179.66M | -15.90M | -275.33M | -209.74M |